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ABSTRACT
Objectives: Cardiovascular risk management (CVRM)
received by patients shows large variation across
countries. In this study we explored the aspects of
primary care organisation associated with key
components of CVRM in coronary heart disease (CHD)
patients.
Design: Observational study.
Setting: 273 primary care practices in Austria,
Belgium, England, Finland, France, Germany, The
Netherlands, Slovenia, Switzerland and Spain.
Participants: A random sample of 4563 CHD patients
identified by coded diagnoses in eight countries, based
on prescription lists and while visiting the practice in
one country each.
Main outcome measure: We performed an audit in
primary care practices in 10 European countries. We
used six indicators to measure key components of
CVRM: risk factor recording, antiplatelet therapy,
influenza vaccination, blood pressure levels (systolic
<140 and diastolic <90 mm Hg), and low-density
lipoprotein cholesterol <2.5 mmol/l. Data from
structured questionnaires were used to construct an
overall measure and six domain measures of practice
organisation based on 39 items. Using multilevel
regression analyses we explored the effects of practice
organisation on CVRM, controlling for patient
characteristics.
Results: Better overall organisation of a primary care
practice was associated with higher scores on three
indicators: risk factor registration (B=0.0307,
p<0.0001), antiplatelet therapy (OR 1.05, p=0.0245)
and influenza vaccination (OR 1.12, p<0.0001). Overall
practice organisation was not found to be related with
recorded blood pressure or cholesterol levels. Only the
organisational domains ‘self-management support’ and
‘use of clinical information systems’ were linked to
three CVRM indicators.
Conclusions: A better organisation of a primary care
practice was associated with better scores on process
indicators of CVRM in CHD patients, but not on
intermediate patient outcome measures. Direct support
for patients and clinicians seemed most influential.
INTRODUCTION
Providing high-quality healthcare for patients
with chronic diseases poses major challenges
for healthcare systems. In many countries
policy makers aim to strengthen the ability of
primary care to provide chronic illness care,
so that large patient populations can be sup-
ported reliably over a long period of time.
ARTICLE SUMMARY
Article focus
▪ This paper focuses on cardiovascular risk man-
agement (CVRM) in patients with coronary heart
diseases (CHD) in primary care across Europe.
▪ A better healthcare organisation is expected to
be related to a higher quality of care.
▪ The aim of our study was to examine which
factors of organisation of a primary care practice
are associated with quality of CVRM in CHD
patients.
Key messages
▪ A primary care practice with overall better prac-
tice organisation had higher performance scores
for risk factor registration, antiplatelet prescrip-
tion and influenza vaccination in CHD patients.
▪ A better organisation of ‘self-management
support’ and ‘clinical information systems’ was
associated with higher scores on three perform-
ance indicators.
▪ The difference between a rather poor score and a
good score on an organisational domain may
improve the outcome up to 30%.
Strengths and limitations of this study
▪ The international character of our study provided
control for contextual confounders, such as spe-
cific reimbursement system or national policies.
▪ Sampling procedures had limitations with respect
to representativeness.
▪ A limitation was that the measures of the organ-
isational domains were post hoc constructed.
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The Chronic Care Model (CCM) proposed that six
organisational components are crucial to achieve this:
‘healthcare organisation’, ‘delivery system design’, ‘deci-
sion support’, ‘clinical information systems, ‘self-
management support’ and ‘community resources and
policies’.1 2 Box 1 shows a brief description of the six
domains. Other organisational models, such as the
Patient-Centered Medical Home,3 speciﬁed similar com-
ponents. Although these models are based on some
research,4–10 their positive impact on clinical and pre-
ventive performance needs further research as imple-
menting best practices for chronic illness management
shows little success.11 While it has been claimed that all
organisational components are important, it would be
informative to get better insight into the relative value of
different domains. For instance, a study on diabetes care
in 17 centres found that ‘delivery system design’ was posi-
tively correlated to outcomes, whereas ‘clinical informa-
tion systems’ and ‘self-management support’ were not
signiﬁcantly associated.6
This paper focuses on cardiovascular risk manage-
ment (CVRM) in patients with coronary heart diseases
(CHD) in primary care across Europe. CHD is a condi-
tion with high morbidity and mortality worldwide.12
Practice guidelines with recommendations for effective
secondary preventive therapy are widely available.13 14
Although the effects of antiplatelet therapy and of
control of blood pressure and serum cholesterol levels
are beyond discussion, research showed that preventive
treatment is suboptimal in Europe and the USA.15 16
Preventive treatment for patients with established CHD
is mostly delivered in primary care, especially in coun-
tries with a strong primary care-oriented healthcare
system. Substantial variation is observed regarding
CVRM received by patients. We expect better healthcare
organisation to be related to a higher quality of care.
The aim of our study was to examine which factors of
organisation of a primary care practice are associated
with quality of CVRM in CHD patients.
METHODS
This study was part of the EPA Cardio project, an inter-
national observational study on cardiovascular risk man-
agement in 10 European countries.17 The participating
countries comprised a convenience sample: Austria,
Belgium, England, Finland, France, Germany, The
Netherlands, Slovenia, Switzerland and Spain. In strati-
ﬁed samples of primary care practices in each of these
countries randomly sampled medical records were
reviewed to provide data on cardiovascular risk manage-
ment and structured questionnaires among participating
general practitioners were used to provide data on prac-
tice organisation. Practices were stratiﬁed according to
urbanisation and size sampling based on regional or
national lists of practices; in Austria and Switzerland a
convenience sample was included. Patients were
included based on coded diagnoses in most countries;
in Austria prescription lists were used to include patients
and in France patients visiting the practice were
included when eligible. Data collection took place in
2008–2009.
Indicators for cardiovascular risk management
Data from medical records were linked to internationally
validated indicators on cardiovascular risk management,
which were developed in a structured Delphi procedure.18
Primary care physician panels from nine countries ini-
tially evaluated 650 indicators for cardiovascular risk
management. This resulted in a core set of 44 indicators,
which were then operationalised in speciﬁc measures
and tested in a pilot study.19 This study is based on
Box 1 Features of the chronic care model
Community resources and policies Provider organisations are linked to community-based resources, for example, exercise programmes,
senior centres and self-help groups
Health care organization Chronic care is seen as a priority with adequate reimbursement
Self-management Support Patients themselves become the principal caregivers, taught to manage their illnesses, with lifestyle
issues under the direct control of the patient.
Self-management support involves collaboratively helping patients and their families acquire the skills
and confidence to manage their chronic illness, providing self-management tools and routinely asses-
sing problems and accomplishments
Delivery system design Planned management of chronic conditions is separated from acute care.
Non-physicians support patient self-management, arrange for routine periodic tasks and ensure
appropriate follow-up
Decision support Evidence-based clinical practice guidelines provide standards for optimal chronic care integrated into
daily practice. Specialist expertise is available without full specialty referral. Guidelines are reinforced
by educational sessions for practice teams
Clinical information systems Registries, a central feature of the Chronic Care Model, are lists of all patients with a particular
chronic condition in a healthcare organisation. Reminder systems help teams comply with practice
guidelines. The system provides feedback showing how each professional is performing on chronic
illness measures. Registries are used to plan both the individual patient care and the population-
based care
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performance indicators related to preventive treatments
in CHD patients. Data were obtained from patient
medical records. The ﬁrst indicator was an aggregate
score which indicated the number of risk factors
recorded per patient. Risk factors considered were:
smoking behaviour, body mass index, physical activity,
blood pressure and cholesterol levels (range 0–5). Five
other indicators, all dichotomous, were: a record of anti-
platelet therapy unless contraindicated, inﬂuenza vaccin-
ation offered, systolic blood pressure <140 mm Hg,
diastolic blood pressure <90 mm Hg, and low-density
lipoprotein (LDL) cholesterol <2.5 mmol/l.
Organisation of primary practice
A large set of questions on practice organisation was
included in structured questionnaires, which were partly
administered in written form and partly in interviews
with the general practitioner in the participating prac-
tices who was the research participating contact person.
These questions mainly comprised items from the
European Practice Assessment (EPA) instrument. This
EPA instrument was previously validated in an inter-
national project.20 We constructed post hoc measures by
linking items to one of the six domains of the Chronic
Care Model as published before.21 All items were formu-
lated positively, with ‘yes’ indicating the presence of a
characteristic. We dichotomised all answers as either
‘yes’ or ‘no’, the latter consisting of ‘no’, ‘missing value’,
or ‘not applicable’. The aggregated scores of the follow-
ing ﬁve CCM domains were positively correlated: ‘health-
care organisation’ (7 items), ‘delivery system design’
(15 items), ‘decision support’ (3 items), ‘clinical infor-
mation systems’ (6 items) and ‘self-management
support’ (4 items). These correlations were highly sig-
niﬁcant with Spearman’s rho values varying from 0.2 to
over 0.6. For that reason, an overall measure of struc-
tured chronic care was deﬁned with a scale from 0 to 5,
with equal weight for each CCM domain. Factor analysis
showed a Cronbach’s α of 0.74. One CCM domain,
‘community resources and policies’ (4 items), was left
out of the overall score due to difference in focus and
lower correlation with other domains.
Data analysis
In order to examine the associations between practice
organisation and performance indicators we applied
multilevel regression analyses, using indicators for car-
diovascular risk management as outcomes. Age and
gender were included as explanatory variables (covari-
ates) at the patient level. The second level was the prac-
tice level at which the organisational measures were
speciﬁed. On this level, we entered two factors: the
domain ‘community resources and policies’ was a pre-
dictor in all analyses; furthermore, we entered either
one of the ﬁve other domains or the overall aggregated
score. The third level was the country level (as a ﬁxed
factor). The analyses were performed for each of the six
outcomes separately. The risk factor recording was
analysed in a linear regression model, while the dichot-
omous outcomes, antiplatelet therapy, inﬂuenza vaccin-
ation, blood pressure and cholesterol levels were
handled in binomial logistic regression models. We con-
sidered p values of 0.05 or less to indicate statistical sig-
niﬁcance. Patients with a missing value were ignored for
that outcome. For the descriptive data presentation we
used SPSS V.16; the regression analyses were conducted
using SAS9.
RESULTS
From the 284 practices in the EPA Cardio study 11 prac-
tices were excluded because of low numbers of patients.
We included 273 primary care practices with data on
4563 patients (table 1). The number of practices varied
from 12 in Finland to 36 in England and Spain. Overall,
one-third of the patients were female; in Switzerland
and Belgium less than 25%; in Finland and England
about 38%. On average patients were over 69 years of
age. Patients in Spain were on average the eldest: over
73 years of age.
Table 2 presents ﬁgures on performance indicators.
Overall performance varied from 46% of the maximum
score for LDL treatment target and 60% for systolic
treatment target up to 87% for antiplatelet therapy and
diastolic treatment target.
Table 3 presents the results of the regression analyses.
Overall better practice organisation was associated with
more reliable risk factor registration (B=0.0307, p<0.0001),
antiplatelet prescribing (OR=1.0533, p=0.0245) and
inﬂuenza vaccination (OR=1.1246, p<0.0001). The same
associations were found for the component ‘clinical infor-
mation systems’. The component ‘self-management
support’ was associated with better risk factor registration
(B=0.1676, p<0.0001), inﬂuenza vaccination (OR 1.55,
p=0.0004) and LDL treatment target (OR 1.15, p=0.0252).
The component ‘delivery system design’ was associated
with better risk factor registration (B=0.0352, p=0.0002)
and vaccination (OR 1.13, p=0.0036). The domains
Table 1 Countries, practices and patients included
Country
Number of
practices
Number of
patients
Percentage
of female
Mean
age
Austria 23 307 36.1 71.5
Belgium 23 269 23.6 66.8
England 36 540 38 67.9
Finland 12 245 38.4 72.1
France 25 346 27.9 68.5
Germany 26 463 36.9 69
The
Netherlands
35 507 29.1 69.4
Slovenia 35 822 35.8 68.2
Spain 36 722 37 73.3
Switzerland 22 342 22.4 67.8
Total 273 4563 33.4 69.5
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‘healthcare organisation’ and ‘decision support’ were
associated with inﬂuenza vaccination only. The domain
‘community resources and policies’ was found to be asso-
ciated with diastolic blood pressure <90 mmHg.
DISCUSSION
Main results
A primary care practice with better practice organisation
showed better performance for risk factor registration,
antiplatelet prescription and inﬂuenza vaccination in
CHD patients. These ﬁndings support the belief that
practice organisation has impact on quality of CVRM in
CHD patients across different healthcare systems
although the observational design does not allow causal
inferences.
In table 4, we illustrate the potential impact of the
associations found in our study. It illustrates that the dif-
ference between a poorly organised practice and a well-
organised practice was associated with smaller and larger
impact on clinical performance. It presents the estimated
outcome in a primary care practice with every predictor
average except for one, varying this predictor from a 10th
percentile score to a 90th percentile score (to avoid focus
on the extremes). With the largest difference as a clear
example, an average patient in an otherwise average prac-
tice on the lower end (10th percentile) regarding self-
management support has a 50% chance of receiving
an inﬂuenza vaccination as opposed to a patient in a
practice on the better end of the range (90th percentile)
having a 79% chance of receiving an inﬂuenza
vaccination.
The ﬁndings related to ‘self-management support’
were of particular interest, given the current focus on
self-management in the health policies of many coun-
tries. In our study the domain related to having informa-
tion leaﬂets available in the practice concerning
cardiovascular diseases (eg, CHD, stroke, hypertension,
stop smoking, etc); presence of a directory of prevention
activities/organisations locally available (eg, gyms,
walking group and weight-watchers); offering written
information on life style regularly; and offering advice
about websites for education on health risks or healthy
life style regularly. It is encouraging that such practical
items are indeed associated with better clinical pro-
cesses, although the causality remains unknown.
The organisational domain ‘clinical information
system’ referred to access to internet and email in the
practice, virus protection, use of a pass word, use of a
computer-supported patient ﬁle system and computer-
generated medication prescriptions. As data on clinical
performance depended on medical records, we actually
measured to some extent performance and also quality
of recording. Optimal use of computerised medical
record systems leads to better scores for practice organ-
ization and clinical performance. But as CVRM mainly is
a collaborative task, healthcare professionals need to be
able to rely on the data recorded.
The relevance of a well organised practice mainly con-
cerned preventive procedures (risk factor registration,
drug prescription and vaccination) rather than intermedi-
ate outcomes of healthcare (blood pressure and choles-
terol levels). However, it should be noted that better
prescribing of antiplatelet therapy has a well-assessed
effect on cardiovascular events and mortality.22 Likewise,
the beneﬁts of inﬂuenza vaccination in preventing com-
plications are well-documented and guidelines recom-
mend vaccination to patients with cardiovascular
diseases.13 14 23 This suggests that better organisation of
primary care was indeed associated with improved survival
and fewer cardiovascular events in patients with CHD.
Previous research found associations between practice
organisation and clinical performance,4–10 24 25 and a
systematic review of trials of organisational interventions
Table 2 Indicators for cardiovascular risk management
Risk factor
registration
(std. deviation)
Anti-platelet
therapy
Influenza
vaccination
Systolic blood
pressure
<140 mm Hg
Diastolic
blood
pressure
<90 mm Hg
Low-density
lipoprotein
cholesterol
<2.5 mmol/l
Austria 80.6 (18.6) 86.4 52.8 61.4 85.9 56.1
Belgium 80.8 (21.2) 90.7 89.2 55.9 85.2 44.8
England 87.5 (16.6) 92 86.7 69.7 95.9 65.5
Finland 70.1 (24.4) 93.2 72.5 50.2 84.4 65.8
France 81.4 (16.5) 90.4 59.1 58.9 89.5 38.2
Germany 80.4 (19.2) 67.5 71.5 58 81.3 30.4
The Netherlands 59.8 (31.7) 85.2 96.4 43.6 85.7 45.1
Slovenia 77.4 (24.8) 93.9 31.8 56.8 79.8 38.2
Spain 58.1 (32.9) 80.2 67.5 72.8 96.1 45.9
Switzerland 76.8 (24.2) 95.3 55.2 65.4 87.2 46.3
Total 74 (26.8) 87 66.1 60.1 87.1 46.3
Percentage of maximum score in risk factor registration (with standard deviation) and percentage of the patients with positive scores for the
binary outcomes is shown (n=4563 patients with coronary heart disease).
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Table 3 Effects of practice organisation characteristics on indicators of cardiovascular risk management
Linear regression Logistic regression
Risk factor
registration
Antiplatelet
therapy
Influenza
vaccination SBP<140 mm Hg DBDP<90 mm Hg LDL<2.5 mmol/l
B p Value OR p Value OR p Value OR p Value OR p Value OR p Value
(a) Primary analyses
Age −0.0042 0.0207 1.0040 NS 1.0688 <0.0001 1.0230 <0.0001 0.9858 0.0036 0.9886 0.0035
Gender
1=female 0.0200 NS 1.7695 <0.0001 1.0619 NS 0.9601 NS 0.9954 NS 0.7192 0.0001
2=male
Chronic care model-composite (score from 0 to 5) 0.0307 <0.0001 1.0533 0.0245 1.1246 <0.0001 1.0028 NS 1.0091 NS 1.0037 NS
Community resources and policies (n=4) 0.0084 NS 0.9049 NS 0.8513 NS 1.0078 NS 1.1556 0.0283 1.1035 NS
(b) Secondary analyses
Healthcare organisation (n=7) 0.0280 NS 1.0371 NS 1.1928 0.0243 0.9938 NS 0.9807 NS 0.9802 NS
Clinical information systems (n=6) 0.0498 0.0236 1.3192 0.0016 1.4768 0.0002 1.0575 NS 1.0558 NS 0.9627 NS
Self-management support (n=4) 0.1676 <0.0001 1.0539 NS 1.5477 0.0004 0.9685 NS –* 1.1469 0.0252
Decision support (n=3) 0.0685 NS 1.1954 NS 1.4338 0.0411 1.0767 NS 1.0664 NS 1.1165 NS
Delivery system design (n=15) 0.0352 0.0002 1.0597 NS 1.1342 0.0036 1.0022 NS 0.9763 NS 1.0033 NS
Results of regression analyses (B values and OR) with p<0.05 as significance level, a three-level model.
Three level model: outcomes on patient level with age and gender as covariates; practice characteristics was the next level and country the third level. Country proved to be a significant factor in
all analyses (p<0.0001, data not shown).
Primary analysis: practice level with two variables: (1) community resources and policies and (2) the Chronic Care Model composite score of the other five domains, comprising healthcare
organisation, clinical information systems, self-management support, decision support and delivery system design.
Secondary analysis: practice level with two variables: (1) community resources and policies and (2) one of the other five domains: healthcare organisation, clinical information systems,
self-management support, decision support or delivery system design. Only the estimates of these last domains are displayed in this analysis.
*Analysis found no estimate.
DBP, diastolic blood pressure; B, effect estimate in regression analysis; LDL, low-density lipoprotein cholesterol level; NS, not significant, significance level at p<0.05; SBP, systolic blood
pressure.
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in CHD patients in primary care found limited evidence
for effects on outcomes such as blood pressure and
serum cholesterol levels.26
In our explorative analysis of the relevance of various
organisational domains, we found differential effects on
performance. The components ‘self-management
support’ and ‘clinical information system’ were found to
be most consistently related to cardiovascular risk man-
agement. We cannot rule out the possibility that our
measures of these domains may have been more accur-
ate than those of other domains or that the participating
primary care practices had speciﬁc characteristics
explaining the ﬁndings. On the contrary, both clinical
information system and self-management are directly
linked to decisions and behaviours of clinicians and
patients, which have known impact on cardiovascular
risk. Clinical information systems may be crucial because
it is a well-known contribution to the other domains.
Self-management support is the one domain targeting
the patient, offering another aspect than the care and
practice-related domains.
The question is how the impact of organisation of
healthcare on (intermediate) patient outcomes can be
optimised. Our study may have missed the power to
detect small effects. Further down the line (system,
process and patient outcomes), more factors become
relevant and inﬂuential and to prove the effect of care
domains subsequently becomes more difﬁcult.
Strengths and weaknesses
The EPA Cardio study was based on random sampling of
patients using well-developed measures of cardiovascular
risk management and practice organisation, although
the measures of the CCM were post hoc constructed.
The international character of our study contributed to
its generalisability and provided control for contextual
confounders, such as speciﬁc reimbursement system or
national policies. The sampling of countries and prac-
tices had limitations with respect to representativeness,
but provided arguably more generalisable evidence than
many trials of organisational changes in healthcare. In
the patient samples women seemed underrepresented.
In various national databases male CHD prevalence is
1.5–2 times the female prevalence.27–29 Particularly in
Belgium and Switzerland low numbers of females were
included which cannot be accounted for. We suggest
that the impact of this on our result was limited, because
sex and age were controlled for in the analyses.
CONCLUSION
Our observational study provided data from a real-life
situation in contrast with many trials of organisational
changes in primary care. We found that a better organised
practice, measured in terms of implementation of the
Chronic Care Model, had better clinical processes in the
targeted cardiovascular domain. Most notably, we found
that ‘clinical information systems’ and ‘self-management
support’ were relevant. The impact on cardiovascular out-
comes was less obvious, which may be due to a range of
factors. Nevertheless, this study reinforces the importance
of strengthening the organisation of primary care prac-
tices for improving their clinical performance.
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